Other adverse effects of TNF-α inhibitors include injection site reactions, upper respiratory tract infections, drug-induced lupus, abnormal liver function tests, and palmoplantar pustulosis, which were noted in US systemic reviews in 2018 and 2019. The gene discussed is TNF; the disease is palmoplantar pustulosis.